Name | Type | Posted | Actions |
|---|---|---|---|
Fingolimod Solicitation - SPE2D2-26-R-0007.pdf | Jun 9, 2026 |
Fingolimod Capsules
Contact and place of performance
Henry Shelly
Not specified
SPE2D2-26-R-0007 Fingolimod Caosules Solicitation
DLA Troop Support is soliciting Fingolimod 0.5 MG Capsules for a requirements-based national contract. This procurement supports pharmaceutical distribution through the DLA and Department of Veterans Affairs (VA) Pharmaceutical Prime Vendor (PPV) programs. The contract structure includes a one-year base period and four one-year option periods. Proposals must be submitted through the DLA Internet Bid Board System (DIBBS) by July 9, 2026. The financial model uses a business-to-business payment structure where the contractor is paid by Prime Vendors rather than the government, and includes a 0.5% Cost Recovery Fee. Technical requirements include unit-of-use packaging and GS1-128 or HIBCC labeling standards. Solicitation SPE2D2-26-R-0007 establishes a national contract for Fingolimod 0.5 MG Capsules. Financial management includes a 0.5% Cost Recovery Fee and quarterly sales reporting.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.